89Zr-daratumumab PET/CT Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CD38-targeted imaging

Filter by location:

Irvine, California1 trial

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

Hoag Memorial Hospital Presbyterian

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.